Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [09/15/2025 10:29 PDT] Bionano Genomics, Inc. (NASDAQ:BNGO), Down By 100% ($3.88) From $3.88 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [09/15/2025 10:29 PDT] Bionano Genomics, Inc. (NASDAQ:BNGO), Down By 100% ($4.1) From $4.1 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [09/15/2025 07:17 PDT] BNGO Expected to Trade Down After Bearish Patterns Develop
• [09/11/2025 12:04 PDT] Bionano Genomics, Inc. (NASDAQ:BNGO), Up By 100% ($4.09) From $4.09 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [09/10/2025 14:18 PDT] Bionano Genomics, Inc. (NASDAQ:BNGO), Up By 100% ($4.34) After BUYINS.NET SqueezeTrigger Report Released on Monday, September 8th 2025 at a Price of $4.34.
• [09/10/2025 11:07 PDT] Bionano Genomics, Inc. (NASDAQ:BNGO), Up By 100% ($4.22) After BUYINS.NET SqueezeTrigger Report Released on Monday, August 25th 2025 at a Price of $4.22.
• [09/08/2025 10:29 PDT] BNGO SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [09/03/2025 07:11 PDT] BNGO Expected to Trade Up Short Term
• [08/26/2025 07:22 PDT] BNGO Expected to Trade Down After Bearish Patterns Develop
• [08/25/2025 12:04 PDT] BNGO SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [08/15/2025 07:17 PDT] BNGO Expected to Trade Up After Bullish Patterns Develop
• [08/04/2025 07:17 PDT] BNGO Expected to Trade Down After Bearish Patterns Develop
• [07/23/2025 07:06 PDT] BNGO Expected to Trade Up After Bullish Patterns Develop